128
Participants
Start Date
February 18, 2020
Primary Completion Date
November 2, 2021
Study Completion Date
November 30, 2021
dexmedetomidine
dexmedetomidine low, middle and high doses are provided as an intravenous bolus loading dose followed by an intravenous maintenance dose infusion throughout the MRI scan
propofol
propofol IV administration will be given if needed to maintain sedation
Duke University Medical Center, Durham
Brody School of Medicine at East Carolina University, Greenville
Vidant Medical Center, Greenville
Children's Healthcare of Atlanta-Egleston, Atlanta
Baptist Health - Wolfson Children's Hospital, Jacksonville
St. Mary's Medical Center, West Palm Beach
University Hospitals Rainbow Babies and Children's Hospital, Cleveland
IU Health Riley Hospital for Children, Indianapolis
M Health Fairview University of Minnesota Medical Center - West Bank, Minneapolis
Arkansas Children's, Little Rock
The Children's Hospital at OUMC, Oklahoma City
Children's Medical Center, Dallas
Texas Children's Hospital, Houston
Lucile Packard Children's Hospital, Stanford, Palo Alto
University of California Davis Medical Center, Sacramento
University of Michigan, C.S. Mott Children's Hospital, Ann Arbor
Ibaraki Children Hospital, Mito
Shikoku Medical Center for Children and Adults, Zentsujichó
Osaka Women's and Children's Hospital, Izumi-shi
Shizuoka Children's Hospital, Shizuoka
Tokyo Metropolitan Children's Medical Center, Fuchū
National Center for Child Health and Development, Setagaya-ku
Osaka City General Hospital, Osaka
Lead Sponsor
Pfizer
INDUSTRY